logo

EbookBell.com

Most ebook files are in PDF format, so you can easily read them using various software such as Foxit Reader or directly on the Google Chrome browser.
Some ebook files are released by publishers in other formats such as .awz, .mobi, .epub, .fb2, etc. You may need to install specific software to read these formats on mobile/PC, such as Calibre.

Please read the tutorial at this link:  https://ebookbell.com/faq 


We offer FREE conversion to the popular formats you request; however, this may take some time. Therefore, right after payment, please email us, and we will try to provide the service as quickly as possible.


For some exceptional file formats or broken links (if any), please refrain from opening any disputes. Instead, email us first, and we will try to assist within a maximum of 6 hours.

EbookBell Team

Resistance Of Targeted Therapies Excluding Antibodies For Lymphomas 1st Ed Andrs J M Ferreri

  • SKU: BELL-7148578
Resistance Of Targeted Therapies Excluding Antibodies For Lymphomas 1st Ed Andrs J M Ferreri
$ 31.00 $ 45.00 (-31%)

5.0

100 reviews

Resistance Of Targeted Therapies Excluding Antibodies For Lymphomas 1st Ed Andrs J M Ferreri instant download after payment.

Publisher: Springer International Publishing
File Extension: PDF
File size: 2.79 MB
Author: Andrés J. M. Ferreri
ISBN: 9783319751832, 9783319751849, 3319751832, 3319751840
Language: English
Year: 2018
Edition: 1st ed.

Product desciption

Resistance Of Targeted Therapies Excluding Antibodies For Lymphomas 1st Ed Andrs J M Ferreri by Andrés J. M. Ferreri 9783319751832, 9783319751849, 3319751832, 3319751840 instant download after payment.

In the last decade, the literature on molecular mechanisms and activated pathways in the different lymphoma categories increased exponentially, which was followed by a more diffuse and successful use of targeted therapies. In this book, expert authors revisit the most relevant aspects of these therapies, with special emphasis on molecular mechanisms and clinical effects of resistance. The knowledge of the underlying mechanisms involved in tumor resistance to target therapies is of paramount importance because they will result in a better selection of patients with sensitive disease and the establishment of suitable combinations of drugs that target different molecules and could overcome the established resistance.

Related Products